Review



decanoylcarnitine chloride c10  (Tocris)


Bioz Verified Symbol Tocris is a verified supplier
Bioz Manufacturer Symbol Tocris manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Tocris decanoylcarnitine chloride c10
    Decanoylcarnitine Chloride C10, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/0477/(%2B%2F-)-Decanoylcarnitine+chloride/pm25770415-39-32-47
    Average 90 stars, based on 1 article reviews
    decanoylcarnitine chloride c10 - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Irradiation:

    Article Title: Development of a Metabolomic Radiation Signature in Urine from Patients Undergoing Total Body Irradiation
    Article Snippet: Debrisoquine sulfate, 4-nitrobenzoic acid (4-NBA), creatinine, uric acid, hypoxanthine, xanthine and Nε,Nε,Nε-Trimethyl- l -lysine hydrochloride (Trimethyl- l -lysine or TML) were obtained from Sigma-Aldrich (St. Louis, MO). (±)-Decanoylcarnitine chloride (Decanoylcarnitine) and (±)-Octanoylcarnitine chloride (Octanoylcarnitine) were obtained from Tocris Bioscience (Ellisville, MO).

    Article Title: Development of a Metabolomic Radiation Signature in Urine from Patients Undergoing Total Body Irradiation
    Article Snippet: Debrisoquine sulfate, 4-nitrobenzoic acid (4- NBA), creatinine, uric acid, hypoxanthine, xanthine and Ne,Ne,NeTrimethyl-L-lysine hydrochloride (Trimethyl-L-lysine or TML) were obtained from Sigma-Aldrich (St. Louis, MO). (6)-Decanoylcarnitine chloride (Decanoylcarnitine) and (6)-Octanoylcarnitine chloride (Octanoylcarnitine) were obtained from Tocris Bioscience (Ellisville, MO).

    Comparison:

    Article Title: Development of a Metabolomic Radiation Signature in Urine from Patients Undergoing Total Body Irradiation
    Article Snippet: Debrisoquine sulfate, 4-nitrobenzoic acid (4-NBA), creatinine, uric acid, hypoxanthine, xanthine and Nε,Nε,Nε-Trimethyl- l -lysine hydrochloride (Trimethyl- l -lysine or TML) were obtained from Sigma-Aldrich (St. Louis, MO). (±)-Decanoylcarnitine chloride (Decanoylcarnitine) and (±)-Octanoylcarnitine chloride (Octanoylcarnitine) were obtained from Tocris Bioscience (Ellisville, MO).

    Article Title: Development of a Metabolomic Radiation Signature in Urine from Patients Undergoing Total Body Irradiation
    Article Snippet: Debrisoquine sulfate, 4-nitrobenzoic acid (4- NBA), creatinine, uric acid, hypoxanthine, xanthine and Ne,Ne,NeTrimethyl-L-lysine hydrochloride (Trimethyl-L-lysine or TML) were obtained from Sigma-Aldrich (St. Louis, MO). (6)-Decanoylcarnitine chloride (Decanoylcarnitine) and (6)-Octanoylcarnitine chloride (Octanoylcarnitine) were obtained from Tocris Bioscience (Ellisville, MO).

    Mouse Assay:

    Article Title: Development of a Metabolomic Radiation Signature in Urine from Patients Undergoing Total Body Irradiation
    Article Snippet: Debrisoquine sulfate, 4-nitrobenzoic acid (4-NBA), creatinine, uric acid, hypoxanthine, xanthine and Nε,Nε,Nε-Trimethyl- l -lysine hydrochloride (Trimethyl- l -lysine or TML) were obtained from Sigma-Aldrich (St. Louis, MO). (±)-Decanoylcarnitine chloride (Decanoylcarnitine) and (±)-Octanoylcarnitine chloride (Octanoylcarnitine) were obtained from Tocris Bioscience (Ellisville, MO).

    Article Title: Development of a Metabolomic Radiation Signature in Urine from Patients Undergoing Total Body Irradiation
    Article Snippet: Debrisoquine sulfate, 4-nitrobenzoic acid (4- NBA), creatinine, uric acid, hypoxanthine, xanthine and Ne,Ne,NeTrimethyl-L-lysine hydrochloride (Trimethyl-L-lysine or TML) were obtained from Sigma-Aldrich (St. Louis, MO). (6)-Decanoylcarnitine chloride (Decanoylcarnitine) and (6)-Octanoylcarnitine chloride (Octanoylcarnitine) were obtained from Tocris Bioscience (Ellisville, MO).



    Similar Products

    n trans feruloyltyramine  (TargetMol)
    94
    TargetMol n trans feruloyltyramine
    HIF inhibits CRC cells growth. (A, B) Cell viability of HCT15 and HCT116 cells treated with trans‐coumaroyltyramine (trans‐Coum), <t>N‐feruloyloctopamine</t> <t>(Feru),</t> <t>N‐trans‐feruloyltyramine</t> (trans‐Feru), disporopsin (Disp), or HIF for 24 h. (C) IC50 values of HIF in HCT15 and HCT116 cells. (D) Cell migration analysis of HCT15 and HCT116 cells following HIF treatment. (E) Colony formation assessment of HCT15 and HCT116 cells after HIF treatment for 24 h. (F) Apoptosis analysis of HCT15 and HCT116 cells after 24 h of HIF treatment. (G, H) Cell cycle distribution analysis of HCT15 and HCT116 cells following HIF treatment for 24 h. (I) Expression levels of cell cycle proteins (Cyclin D1, Cyclin A2, CDK1, CDK2, CDK7) and apoptosis markers (c‐Caspase3, c‐Caspase8). (J, K) The impact of Z‐VAD‐FMK (Z‐VAD) co‐treatment on HIF‐induced cell death in HCT15 and HCT116 cells. ** p < 0.01, *** p < 0.001, **** p < 0.0001; ns, not significant.
    N Trans Feruloyltyramine, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/0477/N-trans-Feruloyltyramine/pmc13045231-185-22-24
    Average 94 stars, based on 1 article reviews
    n trans feruloyltyramine - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    decanoylcarnitine  (Tocris)
    93
    Tocris decanoylcarnitine
    HIF inhibits CRC cells growth. (A, B) Cell viability of HCT15 and HCT116 cells treated with trans‐coumaroyltyramine (trans‐Coum), <t>N‐feruloyloctopamine</t> <t>(Feru),</t> <t>N‐trans‐feruloyltyramine</t> (trans‐Feru), disporopsin (Disp), or HIF for 24 h. (C) IC50 values of HIF in HCT15 and HCT116 cells. (D) Cell migration analysis of HCT15 and HCT116 cells following HIF treatment. (E) Colony formation assessment of HCT15 and HCT116 cells after HIF treatment for 24 h. (F) Apoptosis analysis of HCT15 and HCT116 cells after 24 h of HIF treatment. (G, H) Cell cycle distribution analysis of HCT15 and HCT116 cells following HIF treatment for 24 h. (I) Expression levels of cell cycle proteins (Cyclin D1, Cyclin A2, CDK1, CDK2, CDK7) and apoptosis markers (c‐Caspase3, c‐Caspase8). (J, K) The impact of Z‐VAD‐FMK (Z‐VAD) co‐treatment on HIF‐induced cell death in HCT15 and HCT116 cells. ** p < 0.01, *** p < 0.001, **** p < 0.0001; ns, not significant.
    Decanoylcarnitine, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/0477/(%2B%2F-)-Decanoylcarnitine+chloride/pmc12403441-53-0-4
    Average 93 stars, based on 1 article reviews
    decanoylcarnitine - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier
    rat-specific testosterone kit cat# e-el-0477  (Elabscience Biotechnology)
    90
    Elabscience Biotechnology rat-specific testosterone kit cat# e-el-0477
    HIF inhibits CRC cells growth. (A, B) Cell viability of HCT15 and HCT116 cells treated with trans‐coumaroyltyramine (trans‐Coum), <t>N‐feruloyloctopamine</t> <t>(Feru),</t> <t>N‐trans‐feruloyltyramine</t> (trans‐Feru), disporopsin (Disp), or HIF for 24 h. (C) IC50 values of HIF in HCT15 and HCT116 cells. (D) Cell migration analysis of HCT15 and HCT116 cells following HIF treatment. (E) Colony formation assessment of HCT15 and HCT116 cells after HIF treatment for 24 h. (F) Apoptosis analysis of HCT15 and HCT116 cells after 24 h of HIF treatment. (G, H) Cell cycle distribution analysis of HCT15 and HCT116 cells following HIF treatment for 24 h. (I) Expression levels of cell cycle proteins (Cyclin D1, Cyclin A2, CDK1, CDK2, CDK7) and apoptosis markers (c‐Caspase3, c‐Caspase8). (J, K) The impact of Z‐VAD‐FMK (Z‐VAD) co‐treatment on HIF‐induced cell death in HCT15 and HCT116 cells. ** p < 0.01, *** p < 0.001, **** p < 0.0001; ns, not significant.
    Rat Specific Testosterone Kit Cat# E El 0477, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/0477/rat+testosterone+elisa+kit/pm40490803-86-30-35
    Average 90 stars, based on 1 article reviews
    rat-specific testosterone kit cat# e-el-0477 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    bbwv2 sg1 bbwv2 sp bbwv2 p2 bbwv1 ul1 bbwv1 nig1 h bbwv1 ben bpmv il cb1 cpmv dsmz pv  (DSMZ)
    92
    DSMZ bbwv2 sg1 bbwv2 sp bbwv2 p2 bbwv1 ul1 bbwv1 nig1 h bbwv1 ben bpmv il cb1 cpmv dsmz pv
    HIF inhibits CRC cells growth. (A, B) Cell viability of HCT15 and HCT116 cells treated with trans‐coumaroyltyramine (trans‐Coum), <t>N‐feruloyloctopamine</t> <t>(Feru),</t> <t>N‐trans‐feruloyltyramine</t> (trans‐Feru), disporopsin (Disp), or HIF for 24 h. (C) IC50 values of HIF in HCT15 and HCT116 cells. (D) Cell migration analysis of HCT15 and HCT116 cells following HIF treatment. (E) Colony formation assessment of HCT15 and HCT116 cells after HIF treatment for 24 h. (F) Apoptosis analysis of HCT15 and HCT116 cells after 24 h of HIF treatment. (G, H) Cell cycle distribution analysis of HCT15 and HCT116 cells following HIF treatment for 24 h. (I) Expression levels of cell cycle proteins (Cyclin D1, Cyclin A2, CDK1, CDK2, CDK7) and apoptosis markers (c‐Caspase3, c‐Caspase8). (J, K) The impact of Z‐VAD‐FMK (Z‐VAD) co‐treatment on HIF‐induced cell death in HCT15 and HCT116 cells. ** p < 0.01, *** p < 0.001, **** p < 0.0001; ns, not significant.
    Bbwv2 Sg1 Bbwv2 Sp Bbwv2 P2 Bbwv1 Ul1 Bbwv1 Nig1 H Bbwv1 Ben Bpmv Il Cb1 Cpmv Dsmz Pv, supplied by DSMZ, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/0477/Cowpea+mosaic+virus+(syn%2E+Cowpea+yellow+mosaic+virus)+CPMV/pmc11021446__42003_2024_6170_MOESM2_ESM-24-28-35
    Average 92 stars, based on 1 article reviews
    bbwv2 sg1 bbwv2 sp bbwv2 p2 bbwv1 ul1 bbwv1 nig1 h bbwv1 ben bpmv il cb1 cpmv dsmz pv - by Bioz Stars, 2026-09
    92/100 stars
    		  Buy from Supplier
    issn 0342-0477  (Georg Thieme Verlag KG)
    90
    Georg Thieme Verlag KG issn 0342-0477
    HIF inhibits CRC cells growth. (A, B) Cell viability of HCT15 and HCT116 cells treated with trans‐coumaroyltyramine (trans‐Coum), <t>N‐feruloyloctopamine</t> <t>(Feru),</t> <t>N‐trans‐feruloyltyramine</t> (trans‐Feru), disporopsin (Disp), or HIF for 24 h. (C) IC50 values of HIF in HCT15 and HCT116 cells. (D) Cell migration analysis of HCT15 and HCT116 cells following HIF treatment. (E) Colony formation assessment of HCT15 and HCT116 cells after HIF treatment for 24 h. (F) Apoptosis analysis of HCT15 and HCT116 cells after 24 h of HIF treatment. (G, H) Cell cycle distribution analysis of HCT15 and HCT116 cells following HIF treatment for 24 h. (I) Expression levels of cell cycle proteins (Cyclin D1, Cyclin A2, CDK1, CDK2, CDK7) and apoptosis markers (c‐Caspase3, c‐Caspase8). (J, K) The impact of Z‐VAD‐FMK (Z‐VAD) co‐treatment on HIF‐induced cell death in HCT15 and HCT116 cells. ** p < 0.01, *** p < 0.001, **** p < 0.0001; ns, not significant.
    Issn 0342 0477, supplied by Georg Thieme Verlag KG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/0477/issn+0342+0477/10__1055_slash_a___0949___7081-204-29-20
    Average 90 stars, based on 1 article reviews
    issn 0342-0477 - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    troilite (fes, pdf 37-0477)  (Kermel Inc)
    90
    Kermel Inc troilite (fes, pdf 37-0477)
    HIF inhibits CRC cells growth. (A, B) Cell viability of HCT15 and HCT116 cells treated with trans‐coumaroyltyramine (trans‐Coum), <t>N‐feruloyloctopamine</t> <t>(Feru),</t> <t>N‐trans‐feruloyltyramine</t> (trans‐Feru), disporopsin (Disp), or HIF for 24 h. (C) IC50 values of HIF in HCT15 and HCT116 cells. (D) Cell migration analysis of HCT15 and HCT116 cells following HIF treatment. (E) Colony formation assessment of HCT15 and HCT116 cells after HIF treatment for 24 h. (F) Apoptosis analysis of HCT15 and HCT116 cells after 24 h of HIF treatment. (G, H) Cell cycle distribution analysis of HCT15 and HCT116 cells following HIF treatment for 24 h. (I) Expression levels of cell cycle proteins (Cyclin D1, Cyclin A2, CDK1, CDK2, CDK7) and apoptosis markers (c‐Caspase3, c‐Caspase8). (J, K) The impact of Z‐VAD‐FMK (Z‐VAD) co‐treatment on HIF‐induced cell death in HCT15 and HCT116 cells. ** p < 0.01, *** p < 0.001, **** p < 0.0001; ns, not significant.
    Troilite (Fes, Pdf 37 0477), supplied by Kermel Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/0477/troilite++fes++pdf+37+0477+/10__1007_slash_s10973___019___08480___6-39-0-11
    Average 90 stars, based on 1 article reviews
    troilite (fes, pdf 37-0477) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    HIF inhibits CRC cells growth. (A, B) Cell viability of HCT15 and HCT116 cells treated with trans‐coumaroyltyramine (trans‐Coum), N‐feruloyloctopamine (Feru), N‐trans‐feruloyltyramine (trans‐Feru), disporopsin (Disp), or HIF for 24 h. (C) IC50 values of HIF in HCT15 and HCT116 cells. (D) Cell migration analysis of HCT15 and HCT116 cells following HIF treatment. (E) Colony formation assessment of HCT15 and HCT116 cells after HIF treatment for 24 h. (F) Apoptosis analysis of HCT15 and HCT116 cells after 24 h of HIF treatment. (G, H) Cell cycle distribution analysis of HCT15 and HCT116 cells following HIF treatment for 24 h. (I) Expression levels of cell cycle proteins (Cyclin D1, Cyclin A2, CDK1, CDK2, CDK7) and apoptosis markers (c‐Caspase3, c‐Caspase8). (J, K) The impact of Z‐VAD‐FMK (Z‐VAD) co‐treatment on HIF‐induced cell death in HCT15 and HCT116 cells. ** p < 0.01, *** p < 0.001, **** p < 0.0001; ns, not significant.

    Journal: Advanced Science

    Article Title: Homoisoflavanone Delays Colorectal Cancer Progression via DNA Damage‐Induced Mitochondrial Apoptosis and Parthanatos‐Like Cell Death

    doi: 10.1002/advs.202511406

    Figure Lengend Snippet: HIF inhibits CRC cells growth. (A, B) Cell viability of HCT15 and HCT116 cells treated with trans‐coumaroyltyramine (trans‐Coum), N‐feruloyloctopamine (Feru), N‐trans‐feruloyltyramine (trans‐Feru), disporopsin (Disp), or HIF for 24 h. (C) IC50 values of HIF in HCT15 and HCT116 cells. (D) Cell migration analysis of HCT15 and HCT116 cells following HIF treatment. (E) Colony formation assessment of HCT15 and HCT116 cells after HIF treatment for 24 h. (F) Apoptosis analysis of HCT15 and HCT116 cells after 24 h of HIF treatment. (G, H) Cell cycle distribution analysis of HCT15 and HCT116 cells following HIF treatment for 24 h. (I) Expression levels of cell cycle proteins (Cyclin D1, Cyclin A2, CDK1, CDK2, CDK7) and apoptosis markers (c‐Caspase3, c‐Caspase8). (J, K) The impact of Z‐VAD‐FMK (Z‐VAD) co‐treatment on HIF‐induced cell death in HCT15 and HCT116 cells. ** p < 0.01, *** p < 0.001, **** p < 0.0001; ns, not significant.

    Article Snippet: The structures of N‐feruloyloctopamine, N‐p‐trans‐coumaroyltyramine, N‐trans‐feruloyltyramine, and Disporopsin were identified through comparison with authentic standards, including N‐feruloyloctopamine (66648‐44‐0, Targetmol), N‐p‐trans‐coumaroyltyramine (36417‐86‐4, Targetmol), N‐trans‐feruloyltyramine (66648‐43‐9, Targetmol), and Disporopsin (1430334‐05‐6, BioBioPha) and confirmed by LC‐MS analysis.

    Techniques: Migration, Expressing